Keywords: celltech, royalties, news, receive, sales, reopro, abciximab

Celltech Royalties News

Article | 20 February 1995

Print This

- Celltech is to receive royalties on the sales of ReoPro (abciximab), an antibody-based drug licensed from Centocor and launched this ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in